These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32128574)

  • 41. Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function.
    Clement LT; Plaeger-Marshall S; Haas A; Saxon A; Martin AM
    J Clin Invest; 1988 Mar; 81(3):669-75. PubMed ID: 3257764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.
    Canela A; Maman Y; Huang SN; Wutz G; Tang W; Zagnoli-Vieira G; Callen E; Wong N; Day A; Peters JM; Caldecott KW; Pommier Y; Nussenzweig A
    Mol Cell; 2019 Jul; 75(2):252-266.e8. PubMed ID: 31202577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of topoisomerase II-alpha gene status by dual color chromogenic
    Neama RAA; Habib MA; Ali SA; Al-Khafaji AH; Alqanbar MF
    Indian J Pathol Microbiol; 2017; 60(4):475-480. PubMed ID: 29323058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent otitis media in association with immunodeficiency.
    Mogi G; Maeda S
    Arch Otolaryngol; 1982 Apr; 108(4):204-7. PubMed ID: 6978706
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic implications of advances in our understanding of transitional B-cell development in humans.
    Suryani S; Tangye SG
    Expert Rev Clin Immunol; 2010 Sep; 6(5):765-75. PubMed ID: 20828285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are xid B lymphocytes representative of any normal B cell population. A commentary.
    Mosier DE
    J Mol Cell Immunol; 1985; 2(2):70. PubMed ID: 3880509
    [No Abstract]   [Full Text] [Related]  

  • 47. A mutation in human topoisomerase II alpha whose expression is lethal in DNA repair-deficient yeast cells.
    Walker JV; Nitiss KC; Jensen LH; Mayne C; Hu T; Jensen PB; Sehested M; Hsieh T; Nitiss JL
    J Biol Chem; 2004 Jun; 279(25):25947-54. PubMed ID: 15037624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients.
    Grenda A; Błach J; Szczyrek M; Krawczyk P; Nicoś M; Kuźnar Kamińska B; Jakimiec M; Balicka G; Chmielewska I; Batura-Gabryel H; Sawicki M; Milanowski J
    Cancer Med; 2020 Jan; 9(2):605-614. PubMed ID: 31797573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.
    Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imbalances in subsets of T lymphocytes in an inbred pedigree with Omenn's syndrome.
    Karol RA; Eng J; Cooper JB; Dennison DK; Sawyer MK; Lawrence EC; Marcus DM; Shearer WT
    Clin Immunol Immunopathol; 1983 Jun; 27(3):412-27. PubMed ID: 6223759
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
    Revy P; Muto T; Levy Y; Geissmann F; Plebani A; Sanal O; Catalan N; Forveille M; Dufourcq-Labelouse R; Gennery A; Tezcan I; Ersoy F; Kayserili H; Ugazio AG; Brousse N; Muramatsu M; Notarangelo LD; Kinoshita K; Honjo T; Fischer A; Durandy A
    Cell; 2000 Sep; 102(5):565-75. PubMed ID: 11007475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.
    Wang HY; Ma CA; Zhao Y; Fan X; Zhou Q; Edmonds P; Uzel G; Oliveira JB; Orange J; Jain A
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5127-32. PubMed ID: 23493554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
    Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
    J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Status of topoisomerase-2β protein in all-trans retinoic acid-treated human neuroblastoma (SK-N-SH) cells.
    Bhanothu V; Kondapi AK
    J Cell Biochem; 2019 Apr; 120(4):5169-5182. PubMed ID: 30318608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymph node pathology in primary combined immunodeficiency diseases.
    Facchetti F; Blanzuoli L; Ungari M; Alebardi O; Vermi W
    Springer Semin Immunopathol; 1998; 19(4):459-78. PubMed ID: 9618768
    [No Abstract]   [Full Text] [Related]  

  • 56. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing.
    Gatto S; Gagliardi M; Franzese M; Leppert S; Papa M; Cammisa M; Grillo G; Velasco G; Francastel C; Toubiana S; D'Esposito M; Angelini C; Matarazzo MR
    Nucleic Acids Res; 2017 Jun; 45(10):5739-5756. PubMed ID: 28334849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells.
    Jeon KH; Yu HV; Kwon Y
    Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1126-1133. PubMed ID: 29425806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood.
    Frans G; Moens L; Schaballie H; Wuyts G; Liston A; Poesen K; Janssens A; Rice GI; Crow YJ; Meyts I; Bossuyt X
    J Allergy Clin Immunol; 2017 Jan; 139(1):360-363.e6. PubMed ID: 27531075
    [No Abstract]   [Full Text] [Related]  

  • 59. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mouse carrying genetic defect in the choice between T and B lymphocytes.
    Tokoro Y; Sugawara T; Yaginuma H; Nakauchi H; Terhorst C; Wang B; Takahama Y
    J Immunol; 1998 Nov; 161(9):4591-8. PubMed ID: 9794386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.